Low dose exemestane usage in breast cancer
Low dose exemestane usage in breast cancer
BRCA1 and BRCA2 genes and hereditary breast cancers
Delayed infection exposure as a trigger for childhood ALL
Disruption of BAFF-BCR crosstalk in CLL
Phase Ib/II study of nivolumab in combination with azacytidine in patients with relapsed AML
ZUMA1 trial of CD19 CAR T cells for aggressive NHL
Diverse T lymphocyte population fights leukaemia more effectively
Delayed exposure to common infections causes acute childhood leukaemia
Cerdulatinib demonstrates rapid responses in a phase 2 study for relapsed/refractory NHL
Europa Uomo - improving prostate cancer patients quality of life across Europe
Personalised medicine for rare cancers
Working With Cancer: helping people affected by cancer return to work